Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AMED CoROCO:7575 -0.30%52 PEG Ratio is 2.72 as of Jul. 15, 2026, which is 93% above its 10-year median of 1.41. GuruFocus rates ROCO:7575 with a GF Score™ of 52/100 and a GF Value™ of NT$62.74 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 209 Medical Devices & Instruments companies, AMED Co ranks worse than 66.03% on this metric.
PE Ratio without NRI / 5-Year EBITDA Growth Rate*
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, AMED Co's PE Ratio without NRI is 13.86. AMED Co's 5-Year EBITDA growth rate is 5.10%. Therefore, AMED Co's PEG Ratio for today is 2.72.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for AMED Co's PEG Ratio or its related term are showing as below:
ROCO:7575'
s PEG Ratio Range Over the Past 10 Years
Min: 0.97 Med: 1.41 Max: 4.76
Current: 2.72
During the past 7 years, AMED Co's highest PEG Ratio was 4.76. The lowest was 0.97. And the median was 1.41.
ROCO:7575's PEG Ratio is ranked worse than 66.03% of 209
companies
in the Medical Devices & Instruments industry
Industry Median: 1.96
vs ROCO:7575: 2.72
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
AMED Co (ROCO:7575) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
AMED Co PEG Ratio Related Terms
AMED Co PEG Ratio Historical Data
* Premium members only.
The historical data trend for AMED Co's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:7575 vs ISRG, BDX, MDLN: PEG Ratio Comparison
For the Medical Instruments & Supplies subindustry, AMED Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AMED Co PEG Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AMED Co's PEG Ratio distribution charts can be found below:
* The bar in red indicates where AMED Co's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
AMED Co (ROCO:7575) has a PEG Ratio of 2.72 as of Jul. 15, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on AMED Co and its competitors. This is 93% above median its historical median of 1.41. Over the past decade, AMED Co's PEG Ratio has ranged from 0.97 to 4.76. According to the industry distribution chart, AMED Co ranks #138 out of 209 companies in the Medical Devices & Instruments industry, placing it in the top 66%.
Is AMED Co's PEG Ratio too high?
AMED Co's current PEG Ratio of 2.72 is 93% above median its 10-year median of 1.41. Over the past 10 years, this metric has ranged from a low of 0.97 to a high of 4.76. The Medical Devices & Instruments industry median PEG Ratio is 1.96. AMED Co's value of 2.72 is 38.8% above this industry median. Based on the distribution chart, AMED Co ranks #138 out of 209 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, AMED Co has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does AMED Co's PEG Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, AMED Co ranks #138 out of 209 companies for PEG Ratio. This places AMED Co in the lower half of its industry. The industry median PEG Ratio is 1.96. AMED Co's value of 2.72 is 38.8% above this benchmark. Historically, AMED Co's own PEG Ratio has ranged from 0.97 to 4.76 over the past decade. While the company's 10-year median is 1.41 vs. the industry median of 1.96, AMED Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Devices & Instruments company?
The median PEG Ratio among Medical Devices & Instruments companies is 1.96, based on 209 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AMED Co's current PEG Ratio of 2.72 is 38.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on AMED Co and its competitors. For the Medical Devices & Instruments industry, the median PEG Ratio is 1.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AMED Co's current PEG Ratio is 2.72, which is 93% above median its own 10-year median of 1.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AMED Co stock overvalued right now?
Based on GuruFocus' analysis, AMED Co (ROCO:7575) is currently considered Possible Value Trap. The stock's GF Value™ is NT$62.74, compared to a current price of NT$16.85 — trading 73.1% below its estimated fair value. The current PEG Ratio is 2.72, which is 93% above median its 10-year median of 1.41 and 38.8% above the Medical Devices & Instruments industry median of 1.96. AMED Co's overall GF Score™ is 52/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For AMED Co (ROCO:7575), the current PEG Ratio is 2.72 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AMED Co (ROCO:7575) Overvalued in 2026?
Based on GuruFocus' analysis, AMED Co stock appears to be undervalued.
The current stock price of NT$16.85 is trading 73.1% below its estimated GF Value™ of NT$62.74.
GuruFocus considers AMED Co to be Possible Value Trap.
Key valuation signals for ROCO:7575:
PEG Ratio: 2.72 (93% above median its 10-year median of 1.41)
GF Value™: NT$62.74 vs. price of NT$16.85 (73.1% below fair value)
Industry Position: 38.8% above the Medical Devices & Instruments median (#138 of 209)
No single metric tells the full story. See the ROCO:7575 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AMED Co Ltd is fully committed to the research and development of UV photopolymerized hydrogels. It is a professional research and development and manufacturing company of wound dressing materials, providing proper wound care solutions, and marketing the product under the brand of Heli Dressing.
52GF Score
Get the complete analysis for ROCO:7575
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7575 has been successfully added to your 
